A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions

Bipolar I Disorder

Interventions

DRUG

Aripiprazole

oral, 24mg(4 tablets)/day

DRUG

placebo

oral, 0mg(4tablets)/day

Trial Locations (12)

Hong Kong

Chubu Region

Chugoku Region

Hokkaido Region

Hokuriku Region

Kanto Region

Kinki Region

Kyushu Region

Shikoku Region

Tohoku Region

Seoul

Taipei